SCHEMBL6853542

SCHEMBL6853542

CCCCCCCCCC=CCCCCC(=O)OCC

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.73
▸ CYP3A4 P08684 2/20 0.73
▸ ALOX15 P16050 2/20 0.73
▸ ALDH1A1 P00352 1/20 0.73
▸ TSHR P16473 1/20 0.73
▸ TDP1 Q9NUW8 1/20 0.73
▸ FAAH O00519 4/20 0.70
▸ DGKA P23743 1/20 0.65
▸ PGR P06401 2/20 0.62
▸ ADORA3 P0DMS8 2/20 0.62
▸ NR1I2 O75469 1/20 0.62
▸ PTGS2 P35354 1/20 0.62
▸ PDE4D Q08499 1/20 0.62
▸ PRKCE Q02156 1/20 0.61
▸ PRKCQ Q04759 1/20 0.61
▸ PRKCD Q05655 1/20 0.61
▸ PRKCA P17252 1/20 0.61
▸ TERT O14746 3/20 0.61
▸ CYP1A2 P05177 2/20 0.61
▸ MAPT P10636 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7557819 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL119944 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL588561 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
Ethyl Oleate SCHEMBL2798 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL3847096 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL25490302 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL588560 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
Ethyl Oleate SCHEMBL1896892 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL12842074 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL546545 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6781004-B2 FOR USE AS ACTIVE INGREDIENT IN COSMETIC AND DERMATOLOGICAL APPLICATIONS; WITTIG REACTION; SAPONIFICATION BASF AKTIENGESELLSCHAFT (DE) 2004-08-24 — — US disclosed
US-20020107412-A1 Process for the preparation of cis-6-hexadecenoic acid BASF AKTIENGESELLSCHAFT (DE) 2002-08-08 — — US disclosed
EP-0319123-B1 Process for producing unsaturated fatty acid or unsaturated hydrocarbon AGENCY IND SCIENCE TECHN (JP) 1995-05-17 — — EP disclosed
EP-0319123-A2 Process for producing unsaturated fatty acid or unsaturated hydrocarbon The Agency of Industrial Science and Technology (JP) 1989-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107412-A1 Process for the preparation of cis-6-hexadecenoic acid DECR1, DECR2, DEGS1 HSD17B10 117/4885CYP3A4 827/4885ALOX15 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback